Phenytoin (Eptoin) Loading Dose
For adults with status epilepticus or acute seizures, administer a loading dose of 15-20 mg/kg IV at a rate not exceeding 50 mg/min, followed by maintenance dosing of 100 mg every 6-8 hours. 1
Adult Dosing
Status Epilepticus
- Loading dose: 15-20 mg/kg IV (typically 10-15 mg/kg is also acceptable for non-emergent situations)
- Maximum infusion rate: 50 mg/min (approximately 20 minutes for a 70 kg patient receiving 1000 mg)
- This achieves therapeutic serum concentrations of 10-20 mcg/mL in most patients 1
Multiple studies support the 18 mg/kg dose as highly effective, with 97% of patients achieving therapeutic levels immediately post-infusion 2. Research using 15-18 mg/kg consistently demonstrates therapeutic levels within 10 minutes of rapid IV loading 2.
Non-Emergent Loading
- Loading dose: 10-15 mg/kg IV
- Same maximum infusion rate of 50 mg/min
- Follow with maintenance doses every 6-8 hours 1
Pediatric Dosing
Children and Adolescents
- Loading dose: 15-20 mg/kg IV (higher end of range preferred)
- Maximum infusion rate: 1-3 mg/kg/min OR 50 mg/min, whichever is slower 3
- This dosing reliably produces therapeutic concentrations of 10-20 mcg/mL 3
A UK audit confirmed that 18 mg/kg achieves therapeutic levels in most children, with 77% reaching target concentrations 4.
Neonates
- Loading dose: 10 mg/kg IV (lower than older children)
- Maximum rate: 1-3 mg/kg/min
- Neonates have increased toxicity risk due to decreased protein binding; phenobarbital is preferred in this age group 3
Critical Administration Details
Infusion Preparation and Monitoring
- Dilute in normal saline only (never use dextrose-containing solutions due to precipitation risk) 3, 1
- Final concentration should be ≥5 mg/mL for infusions 1
- Use 0.22-0.55 micron in-line filter for infusions 1
- Complete infusion within 1-4 hours of preparation 1
- Continuous cardiac monitoring is mandatory during administration 3, 1
Monitoring Requirements
- Monitor ECG, blood pressure, and respiratory function continuously 1
- Reduce infusion rate if heart rate decreases by 10 beats/min 3
- Watch for hypotension and arrhythmias, especially with rapid infusion 3
- Measure serum phenytoin levels to guide subsequent dosing 1
Special Populations
Overweight Patients (>120% IBW)
Use adjusted body weight (AdjBW) rather than actual body weight for dose calculation. A study of 195 patients demonstrated that dosing based on AdjBW resulted in 74% achieving therapeutic levels versus only 57% with actual body weight, with fewer supratherapeutic levels 5.
Renal/Hepatic Impairment or Hypoalbuminemia
Monitor unbound (free) phenytoin concentrations rather than total levels, as the fraction of unbound drug increases in these conditions 1.
Elderly Patients
Consider lower or less frequent dosing due to decreased phenytoin clearance with age 1.
Common Pitfalls to Avoid
Never use IM administration for status epilepticus - peak levels may take up to 24 hours, making it ineffective for acute seizure control 1
Avoid dextrose-containing solutions - phenytoin precipitates in dextrose; use only normal saline 3, 1
Do not exceed maximum infusion rates - rapid administration significantly increases risk of hypotension and cardiac arrhythmias 3, 1
Flush IV line with saline after administration to prevent local venous irritation from the alkaline solution 1
Fosphenytoin is preferred when available due to lower risk of adverse cardiac effects and soft tissue injury 3, 6
Alternative Considerations
If phenytoin fails to terminate seizures, consider second-line agents including IV benzodiazepines, short-acting barbiturates, valproate (20-30 mg/kg at 40 mg/min), or levetiracetam (30-50 mg/kg) 6, 1. Valproate may be given more quickly than phenytoin with fewer adverse effects 6.